These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 25950128

  • 1. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
    van Aardt MC, Dreyer G, Pienaar HF, Karlsen F, Hovland S, Richter KL, Becker P.
    Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX, Retrospective International Survey and HPV Time Trends Study Group.
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
    Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J.
    Int J Cancer; 2014 Mar 15; 134(6):1389-98. PubMed ID: 23929250
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa.
    De Vuyst H, Ndirangu G, Moodley M, Tenet V, Estambale B, Meijer CJ, Snijders PJ, Clifford G, Franceschi S.
    Int J Cancer; 2012 Aug 15; 131(4):949-55. PubMed ID: 21960453
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
    Darwich L, Cañadas MP, Sirera G, Alameda F, Forcada P, Delas J, Fernández I, Llatjós M, Coll J, Clotet B, Videla S.
    Int J Gynecol Cancer; 2011 Nov 15; 21(8):1486-90. PubMed ID: 21892092
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
    ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X.
    Int J Cancer; 1992 Jun 19; 51(4):515-21. PubMed ID: 1318265
    [Abstract] [Full Text] [Related]

  • 7. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras.
    Ferrera A, Melchers WJ, Velema JP, Figueroa M.
    Am J Trop Med Hyg; 1997 Aug 19; 57(2):138-41. PubMed ID: 9288804
    [Abstract] [Full Text] [Related]

  • 8. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL, Wiklund F, Angström T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J.
    N Engl J Med; 1999 Nov 25; 341(22):1633-8. PubMed ID: 10572150
    [Abstract] [Full Text] [Related]

  • 9. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE, Critchlow CW, Sow PS, Touré P, N'Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):100-9. PubMed ID: 16418512
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.
    Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Muñoz N, Meijer CJ, Herrero R.
    Int J Cancer; 2003 Oct 20; 107(1):127-33. PubMed ID: 12925967
    [Abstract] [Full Text] [Related]

  • 11. [Human papillomavirus types in women with cervical cancer in Haifa District].
    Siegler E, Lahat N, Shiner M, Mackuli L, Aroudi Y, Shapiro S, Auslander R, Lavie O.
    Harefuah; 2011 Nov 20; 150(11):837-41, 876. PubMed ID: 22428203
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
    Patel KR, Vajaria BN, Begum R, Desai A, Patel JB, Shah FD, Shukla SN, Patel PS.
    J Oral Pathol Med; 2014 Apr 20; 43(4):293-7. PubMed ID: 24372728
    [Abstract] [Full Text] [Related]

  • 13. The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers.
    Powell N, Boyde A, Tristram A, Hibbitts S, Fiander A.
    Int J Cancer; 2009 Nov 15; 125(10):2425-7. PubMed ID: 19585507
    [Abstract] [Full Text] [Related]

  • 14. HPV genotypes in invasive cervical cancer in Danish women.
    Kirschner B, Junge J, Holl K, Rosenlund M, Collas de Souza S, Quint W, Molijn A, Jenkins D, Schledermann D.
    Acta Obstet Gynecol Scand; 2013 Sep 15; 92(9):1023-31. PubMed ID: 23763577
    [Abstract] [Full Text] [Related]

  • 15. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, Newman M, Sharma R, Saville M, Garland SM.
    Int J Cancer; 2017 Oct 15; 141(8):1576-1584. PubMed ID: 28677147
    [Abstract] [Full Text] [Related]

  • 16. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):577-86. PubMed ID: 15840880
    [Abstract] [Full Text] [Related]

  • 17. Oncogenic viral prevalence in invasive vulvar cancer specimens from human immunodeficiency virus-positive and -negative women in Botswana.
    Tesfalul M, Simbiri K, Wheat CM, Motsepe D, Goldbach H, Armstrong K, Hudson K, Kayembe MK, Robertson E, Kovarik C.
    Int J Gynecol Cancer; 2014 May 20; 24(4):758-65. PubMed ID: 24651632
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea.
    Park EK, Cho H, Lee SH, Lee SG, Lee SY, Kim KH, Lee CH, Chung JS, Kwak IS.
    J Korean Med Sci; 2014 Jan 20; 29(1):32-7. PubMed ID: 24431902
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study.
    Naucler P, Mabota da Costa F, da Costa JL, Ljungberg O, Bugalho A, Dillner J.
    J Gen Virol; 2011 Dec 20; 92(Pt 12):2784-2791. PubMed ID: 21900420
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.
    Mbulawa ZZ, Coetzee D, Williamson AL.
    BMC Infect Dis; 2015 Oct 26; 15():459. PubMed ID: 26502723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.